Clinical Trials Browser

OTHER × Melanoma × entinostat × Clear all

NCT03765229 2024-01-10

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Phase 2 Completed

11 enrolled 12 charts

Melanoma